Literature DB >> 18630221

Drug promotional practices in Mumbai: a qualitative study.

Nobhojit Roy1, Neha Madhiwalla, Sanjay A Pai.   

Abstract

We conducted a qualitative study to determine the range of promotional practices influencing drug usage in Mumbai. Open-ended interviews were conducted with 15 senior executives in drug companies, 25 chemists and 25 doctors; focus group discussions were held with 36 medical representatives. The study provided a picture of what might be described as an unholy alliance: manufacturers, chemists and doctors conspire to make profits at the expense of consumers and the public's health, even as they negotiate with each other on their respective shares of these profits. Misleading information, incentives and unethical trade practices were identified as methods to increase the prescription and sale of drugs. Medical representatives provide incomplete medical information to influence prescribing practices; they also offer incentives including conference sponsorship. Doctors may also demand incentives, as when doctors' associations threaten to boycott companies that do not comply with their demands for sponsorship. Manufacturers, chemists and medical representatives use various unethical trade practices. Of particular interest was the finding that chemists are major players in this system, providing drug information directly to patients. The study also reinforced our impression that medical representatives are the least powerful of the four groups.

Entities:  

Mesh:

Year:  2007        PMID: 18630221     DOI: 10.20529/IJME.2007.020

Source DB:  PubMed          Journal:  Indian J Med Ethics        ISSN: 0974-8466


  12 in total

1.  Provider performance in treating poor patients--factors influencing prescribing practices in lao PDR: a cross-sectional study.

Authors:  Lamphone Syhakhang; Douangdao Soukaloun; Göran Tomson; Max Petzold; Clas Rehnberg; Rolf Wahlström
Journal:  BMC Health Serv Res       Date:  2011-01-06       Impact factor: 2.655

2.  India's ban on antimicrobial fixed-dose combinations: winning the battle, losing the war?

Authors:  Giorgia Sulis; Richeek Pradhan; Anita Kotwani; Sumanth Gandra
Journal:  J Pharm Policy Pract       Date:  2022-04-28

3.  Adequacy of pharmacological information provided in pharmaceutical drug advertisements in African medical journals.

Authors:  Kazeem A Oshikoya; Idowu O Senbanjo; Ayo Soipe
Journal:  Pharm Pract (Granada)       Date:  2009-03-15

4.  Qualitative insights into promotion of pharmaceutical products in Bangladesh: how ethical are the practices?

Authors:  Mahrukh Mohiuddin; Sabina Faiz Rashid; Mofijul Islam Shuvro; Nahitun Nahar; Syed Masud Ahmed
Journal:  BMC Med Ethics       Date:  2015-12-01       Impact factor: 2.652

Review 5.  Interaction and medical inducement between pharmaceutical representatives and physicians: a meta-synthesis.

Authors:  Shahrzad Salmasi; Long Chiau Ming; Tahir Mehmood Khan
Journal:  J Pharm Policy Pract       Date:  2016-11-17

6.  Prevalence of Polypharmacy, Hyperpolypharmacy and Potentially Inappropriate Medication Use in Older Adults in India: A Systematic Review and Meta-Analysis.

Authors:  Akshaya S Bhagavathula; Kota Vidyasagar; Manik Chhabra; Muhammed Rashid; Rishabh Sharma; Deepak K Bandari; Daniela Fialova
Journal:  Front Pharmacol       Date:  2021-05-19       Impact factor: 5.810

7.  A survey of pharmaceutical company representative interactions with doctors in Libya.

Authors:  Mustafa A Alssageer; Stefan R Kowalski
Journal:  Libyan J Med       Date:  2012-09-18       Impact factor: 1.657

8.  Doctors' opinions of information provided by Libyan pharmaceutical company representatives.

Authors:  Mustafa A Alssageer; Stefan R Kowalski
Journal:  Libyan J Med       Date:  2012-11-28       Impact factor: 1.657

9.  Antibiotic Resistance in India: Drivers and Opportunities for Action.

Authors:  Ramanan Laxminarayan; Ranjit Roy Chaudhury
Journal:  PLoS Med       Date:  2016-03-02       Impact factor: 11.069

10.  Irrational fixed dose combinations of psychotropic drugs in India: Cause of concern.

Authors:  Madhusudan Singh Solanki; Girish Banwari
Journal:  Indian J Pharmacol       Date:  2016 Jul-Aug       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.